Ovothiols for the treatment of chronic low-grade systemic inflammation (CLGSI) and related diseases.
Patent
Publication Date:
2019
abstract:
The use of ovothiols for inflammatory diseases also disberes-related is disclosed
Iris type:
6.1 Brevetto
List of contributors: